Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Chengdu, 610041610041, Sichuan, China.
Mol Neurobiol. 2024 Apr;61(4):2265-2269. doi: 10.1007/s12035-023-03677-1. Epub 2023 Oct 23.
DnaJ heat shock protein family member C7 gene (DNAJC7) has been identified as a genetic risk factor for amyotrophic lateral sclerosis (ALS). In our study, we aimed to screen for rare variants in DNAJC7 in a large cohort of Chinese ALS patients, and investigate the genotype-phenotype correlation of DNAJC7 in ALS. Four (0.19%) variants of DNAJC7 with minor allele frequency (MAF) < 0.1% among 2124 patients were identified, including 1 protein-truncating variant and 3 missense variants, all of which were predicted to be damaging. The patients carrying variants of DNAJC7 in our cohort tented to have a limb onset and a relatively slow disease progression. However, burden analysis did not show an enrichment of rare damaging variants in ALS patients compared to controls. Further analysis involving diverse regions and larger sample size is necessary to elucidate the role of DNAJC7 in the pathogenicity of ALS.
DNAJ 热休克蛋白家族成员 C7 基因 (DNAJC7) 已被确定为肌萎缩侧索硬化症 (ALS) 的遗传风险因素。在我们的研究中,我们旨在对一大群中国 ALS 患者的 DNAJC7 进行罕见变异筛查,并研究 DNAJC7 在 ALS 中的基因型-表型相关性。在 2124 名患者中,发现了 4 种 DNAJC7 变异体,其次要等位基因频率 (MAF) < 0.1%,包括 1 种蛋白截断变异体和 3 种错义变异体,所有这些变异体均被预测为有害。携带 DNAJC7 变异体的患者倾向于具有肢体起病和相对较慢的疾病进展。然而,与对照组相比,负担分析并未显示 ALS 患者中罕见有害变异体的富集。需要涉及不同区域和更大样本量的进一步分析,以阐明 DNAJC7 在 ALS 发病机制中的作用。